Wei Lian
-
- Pituitary Gland Disorders and Treatments 63
- Growth Hormone and Insulin-like Growth Factors 29
- Genetics top 5%
- Glioma Diagnosis and Treatment 14
-
- MicroRNA in disease regulation 4
-
- Meningioma and schwannoma management 11
- Surgery top 10%
- Adrenal and Paraganglionic Tumors 22
- Head and Neck Surgical Oncology 5
-
- TGF-β signaling in diseases 5
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Wei Lian
73 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 94
- Endocrinology, Diabetes and Metabolism 612
- Genetics 233
- Cancer Research 119
- Epidemiology 241
- Surgery 302
Countries citing papers authored by Wei Lian
This map shows the geographic impact of Wei Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Lian more than expected).
Fields of papers citing papers by Wei Lian
This network shows the impact of papers produced by Wei Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Lian. The network helps show where Wei Lian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Lian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 23 | |
| 8 | 2019 | 4 | |
| 9 | 2019 | 17 | |
| 10 | 2019 | 7 | |
| 11 | 2018 | 14 | |
| 12 | 2018 | 1 | |
| 13 | 2017 | 20 | |
| 14 | 2017 | 20 | |
| 15 | 2017 | 8 | |
| 16 | 2016 | 1 | |
| 17 | 2016 | 46 | |
| 18 | 2016 | 13 | |
| 19 | [Causes and treatment of acute visual dysfunction after transsphenoidal surgery of pituitary adenoma]. | 2015 | 1 |
| 20 | 2014 | 2 |
About Wei Lian
Wei Lian is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics, Surgery, Cancer Research and Epidemiology, having authored 83 papers that have together received 1.0k indexed citations. Recurring topics across this work include Pituitary Gland Disorders and Treatments (63 papers), Growth Hormone and Insulin-like Growth Factors (29 papers), Adrenal and Paraganglionic Tumors (22 papers), Glioma Diagnosis and Treatment (14 papers), Meningioma and schwannoma management (11 papers), Head and Neck Surgical Oncology (5 papers), TGF-β signaling in diseases (5 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (612 citations), Genetics (233 citations), Cancer Research (119 citations), Epidemiology (241 citations) and Surgery (302 citations). Wei Lian has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Bing Xing, Kan Deng, Renzhi Wang, Yong Yao, Xiaopeng Guo, Lu Gao, Ming Feng, Xinjie Bao, Zihao Wang and Xiaohai Liu. Their work appears in journals such as World Neurosurgery, Frontiers in Endocrinology, Pituitary, Medicine and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.